Abstract
Current treatments of solid tumors often involve using both chemotherapy and radiotherapy in parallel. Concomitant chemotherapy and radiation therapy is the standard of care for patients with advanced (stages III and IV) head and neck cancer1,2 and non-small-cell lung cancer.3,4Chemotherapeutic agents generally utilized include radiosensitizing agents like taxanes (e.g., paclitaxel) and platinum compounds (e.g., carboplatin). This approach has improved local control and median survival in these patients.
Original language | English |
---|---|
Title of host publication | Targeted Delivery of Small and Macromolecular Drugs |
Publisher | CRC Press |
Pages | 53-82 |
Number of pages | 30 |
ISBN (Electronic) | 9781420087734 |
ISBN (Print) | 9781420087727 |
DOIs | |
State | Published - Jan 1 2010 |